| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A healing space
|
Jouret, Jill
|
|
2012
|
13 |
9 |
p. 866-867
2 p.
|
artikel
|
| 2 |
Anterior resection syndrome
|
Bryant, Catherine LC
|
|
2012
|
13 |
9 |
p. e403-e408
nvt p.
|
artikel
|
| 3 |
A roadmap for accelerated drug approval in breast cancer?
|
Perez-Garcia, Jose
|
|
2012
|
13 |
9 |
p. 850-851
2 p.
|
artikel
|
| 4 |
Ayurveda: alternative or complementary?
|
O'Cathail, Sean
|
|
2012
|
13 |
9 |
p. 865-
1 p.
|
artikel
|
| 5 |
Breast Cancer and the Environment
|
Wolff, Mary S
|
|
2012
|
13 |
9 |
p. 868-
1 p.
|
artikel
|
| 6 |
Carfilzomib for multiple myeloma
|
Tanday, Sanjay
|
|
2012
|
13 |
9 |
p. e373-
1 p.
|
artikel
|
| 7 |
Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia
|
Thomas, Deborah
|
|
2012
|
13 |
9 |
p. 860-862
3 p.
|
artikel
|
| 8 |
Circulating tumour cells in early breast cancer
|
De Mattos-Arruda, Leticia
|
|
2012
|
13 |
9 |
p. e370-
1 p.
|
artikel
|
| 9 |
Circulating tumour cells in early breast cancer
|
Nair, Viswam S
|
|
2012
|
13 |
9 |
p. e370-e371
nvt p.
|
artikel
|
| 10 |
Circulating tumour cells in early breast cancer – Authors' reply
|
Lucci, Anthony
|
|
2012
|
13 |
9 |
p. e371-
1 p.
|
artikel
|
| 11 |
Combination treatment for metastatic breast cancer
|
Tanday, Sanjay
|
|
2012
|
13 |
9 |
p. e374-
1 p.
|
artikel
|
| 12 |
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
|
Harshman, Lauren C
|
|
2012
|
13 |
9 |
p. 927-935
9 p.
|
artikel
|
| 13 |
Confronting Hereditary Breast and Ovarian Cancer
|
Evans, Gareth
|
|
2012
|
13 |
9 |
p. 867-868
2 p.
|
artikel
|
| 14 |
Difficulty in predicting survival in metastatic renal cancer
|
Powles, Tom
|
|
2012
|
13 |
9 |
p. 859-860
2 p.
|
artikel
|
| 15 |
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial
|
Mattano Jr, Leonard A
|
|
2012
|
13 |
9 |
p. 906-915
10 p.
|
artikel
|
| 16 |
Epilepsy meets cancer: when, why, and what to do about it?
|
Weller, Michael
|
|
2012
|
13 |
9 |
p. e375-e382
nvt p.
|
artikel
|
| 17 |
European Commission proposals do not impress researchers
|
Senior, Kathryn
|
|
2012
|
13 |
9 |
p. 864-
1 p.
|
artikel
|
| 18 |
Evolving role of rituximab in leukaemia and lymphoma
|
Sharma, Sharan Prakash
|
|
2012
|
13 |
9 |
p. e374-
1 p.
|
artikel
|
| 19 |
First do no harm: counting the cost of chasing drug efficacy
|
The Lancet Oncology,
|
|
2012
|
13 |
9 |
p. 849-
1 p.
|
artikel
|
| 20 |
Glioblastoma therapy in the elderly: one age does not fit all
|
Nghiemphu, Phioanh Leia
|
|
2012
|
13 |
9 |
p. 857-858
2 p.
|
artikel
|
| 21 |
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
|
Biondi, Andrea
|
|
2012
|
13 |
9 |
p. 936-945
10 p.
|
artikel
|
| 22 |
Increased evidence for use of chemotherapy in pregnancy
|
Mir, Olivier
|
|
2012
|
13 |
9 |
p. 852-854
3 p.
|
artikel
|
| 23 |
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
|
Di Giacomo, Anna Maria
|
|
2012
|
13 |
9 |
p. 879-886
8 p.
|
artikel
|
| 24 |
Ipilimumab with fotemustine in metastatic melanoma
|
Garbe, Claus
|
|
2012
|
13 |
9 |
p. 851-852
2 p.
|
artikel
|
| 25 |
Learning from disease heterogeneity
|
Gaudet, Mia M
|
|
2012
|
13 |
9 |
p. 862-863
2 p.
|
artikel
|
| 26 |
Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies
|
|
|
2012
|
13 |
9 |
p. 946-956
11 p.
|
artikel
|
| 27 |
Radical prostatectomy versus observation for prostate cancer
|
Mullins, Jim
|
|
2012
|
13 |
9 |
p. e372-
1 p.
|
artikel
|
| 28 |
Real-time tumour tracking in particle therapy: technological developments and future perspectives
|
Riboldi, Marco
|
|
2012
|
13 |
9 |
p. e383-e391
nvt p.
|
artikel
|
| 29 |
Secondary skin-cancer risk after kidney transplantation
|
Burki, Talha Khan
|
|
2012
|
13 |
9 |
p. e373-
1 p.
|
artikel
|
| 30 |
Steroids and risk of osteonecrosis in ALL: take a break
|
van den Heuvel-Eibrink, Marry M
|
|
2012
|
13 |
9 |
p. 855-857
3 p.
|
artikel
|
| 31 |
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial
|
Ismael, Gustavo
|
|
2012
|
13 |
9 |
p. 869-878
10 p.
|
artikel
|
| 32 |
Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction
|
Seth, Rohit
|
|
2012
|
13 |
9 |
p. e392-e402
nvt p.
|
artikel
|
| 33 |
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
|
Malmström, Annika
|
|
2012
|
13 |
9 |
p. 916-926
11 p.
|
artikel
|
| 34 |
Therapeutic drug targets in colorectal cancer
|
Gilbert, Judith A
|
|
2012
|
13 |
9 |
p. e372-
1 p.
|
artikel
|
| 35 |
Treating advanced radioresistant differentiated thyroid cancer
|
Bible, Keith C
|
|
2012
|
13 |
9 |
p. 854-855
2 p.
|
artikel
|
| 36 |
Treatment of breast cancer during pregnancy: an observational study
|
Loibl, Sibylle
|
|
2012
|
13 |
9 |
p. 887-896
10 p.
|
artikel
|
| 37 |
Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
|
Leboulleux, Sophie
|
|
2012
|
13 |
9 |
p. 897-905
9 p.
|
artikel
|
| 38 |
Voices from the front: September
|
Mastrianni, David M
|
|
2012
|
13 |
9 |
p. 868-
1 p.
|
artikel
|
Tijdschrift beschrijving